Vision

▬

Become a leading gene editing company to provide curative solutions for genetic diseases that have no cures or lack simple treatments today.

Mission

▬

Build precision gene editing technology platform and develop a clinical pipeline of programmable gene therapy products that aresafe and effective.

Strategy

▬

Focus on in vivo gene editing in the near term with future expansion into ex-vivo gene edited cell therapy.

Quality

Creativity

Collaboration

Transparency

Beijing

Hong Kong

Boston (Zingen Therapeutics)